transplantation in hodgkin lymphoma in the context of targeted immunotherapy
Published 2 years ago • 126 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
1:28
the role of autosct in hodgkin lymphoma
-
2:39
new findings and challenges in the use of immunotherapy in hodgkin lymphoma
-
1:43
the addition of immunotherapy to the front-line treatment of as hodgkin lymphoma
-
2:13
reinforcing transplantation with consolidation therapy in hodgkin lymphoma
-
1:59
updates on the use of nivolumab in hodgkin lymphoma & how this agent may impact treatment
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
6:16
allogeneic stem cell transplant: kat's story
-
8:06
findings from arms 6 and 7 of the epcore nhl-2 trial: epcoritamab in newly diagnosed fl
-
2:11
allohsct in hodgkin lymphoma post pd-1 inhibitors
-
1:13
efficacy of transplantation in hl
-
1:21
the role of transplant in the era of new treatments for lymphoma and cll
-
1:43
maintenance nivolumab in post-stem cell transplant hodgkin lymphoma
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
2:50
nivolumab and allogeneic transplantation in r/r classical hodgkin lymphoma
-
2:15
hovon/llpc transplant brave: novel salvage chemotherapy for r/r hodgkin lymphoma
-
1:47
advances in hodgkin lymphoma treatment: moving away from abvd and beacopp
-
4:21
an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
-
1:57
the current hodgkin lymphoma immunotherapy landscape
-
1:44
treatment options for transplant-ineligibile hl patients